BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32021962)

  • 1. Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer.
    Ohzawa H; Kumagai Y; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Kawarai Lefor A; Sata N; Kitayama J
    Ann Gastroenterol Surg; 2020 Jan; 4(1):84-93. PubMed ID: 32021962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer.
    Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
    Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
    Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.
    Ohzawa H; Saito A; Kumagai Y; Kimura Y; Yamaguchi H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Oncol Rep; 2020 Apr; 43(4):1081-1088. PubMed ID: 32323853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.
    Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R
    Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
    Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
    Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
    Liu X; Chu KM
    J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased exosome-delivered miR-486-5p is responsible for the peritoneal metastasis of gastric cancer cells by promoting EMT progress.
    Lin XM; Wang ZJ; Lin YX; Chen H
    World J Surg Oncol; 2021 Oct; 19(1):312. PubMed ID: 34686196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
    Xiao CT; Lai WJ; Zhu WA; Wang H
    Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.
    Sun Y; Hou Y; Meng G; Han P; Zhao Y; Wang H; Xu M; Wang Y; Qiu J; Peng J; Shao L; Sun L; Hou M
    Br J Haematol; 2021 Sep; 194(6):1045-1052. PubMed ID: 34337736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
    Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
    J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential.
    Feng Y; Bai F; You Y; Bai F; Wu C; Xin R; Li X; Nie Y
    Exp Ther Med; 2018 Dec; 16(6):4602-4608. PubMed ID: 30546395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
    Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
    Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.